Roche announced the grand opening of the Roche Genentech Innovation Center Boston, expanding its US research presence. The center in Allston will be a Cardiovascular, Renal and Metabolism hub, integrating R&D from discovery to clinical development. It will also house data science and AI specialists to drive innovation in drug discovery. This expansion reflects Roche and Genentech's commitment to Boston and the broader US life sciences ecosystem. The new center is part of a significant USD 50 billion investment in US manufacturing and R&D. This investment builds upon existing milestones in North Carolina and Oregon. The Innovation Center underscores Roche's dedication to scientific collaboration within Boston's vibrant life sciences community. The 95,000 square meter facility will accommodate up to 500 employees. Local officials expressed enthusiasm for the job creation and strengthened innovation in Massachusetts and Boston.